Yury I Miller Selected Research

Atherosclerosis

10/2023	Macrophage inflammarafts in atherosclerosis.
1/2020	Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts.
1/2019	A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.
1/2018	AIBP protects against metabolic abnormalities and atherosclerosis.
1/2018	Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish.
1/2018	Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux.
1/2018	Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
11/2017	Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis.
4/2017	Oxidized cholesteryl esters and inflammation.
1/2017	Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yury I Miller Research Topics

Disease

40	Atherosclerosis 10/2023 - 01/2003
25	Inflammation (Inflammations) 01/2023 - 11/2005
6	Neuroinflammatory Diseases 01/2024 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2005
6	Hypercholesterolemia 01/2018 - 04/2009
5	Pain (Aches) 01/2023 - 01/2018
5	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2010
3	Hyperalgesia 01/2023 - 01/2018
3	Hypertriglyceridemia 01/2018 - 08/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 01/2011
2	Glaucoma 01/2024 - 10/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 01/2021
2	Rupture 01/2021 - 01/2010
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Rheumatoid Arthritis 01/2020 - 11/2012
2	Acute Lung Injury 01/2020 - 01/2019
2	Infections 01/2020 - 01/2020
2	Pathologic Processes 01/2020 - 10/2012
2	Fatty Liver 01/2018 - 01/2014
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 01/2011
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017 - 04/2016
2	Thrombosis (Thrombus) 05/2014 - 10/2013
2	Stroke (Strokes) 01/2010 - 04/2009
2	Myocardial Infarction 01/2010 - 04/2009
1	Disease Progression 10/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Wounds and Injuries (Trauma) 01/2020
1	COVID-19 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Weight Gain 01/2018
1	Glucose Intolerance 01/2018
1	Lung Injury 01/2018
1	Costello Syndrome 01/2017
1	Pancreatitis 08/2015
1	Xanthomatosis (Xanthoma) 08/2015

Drug/Important Bio-Agent (IBA)

24	LipidsIBA 10/2023 - 12/2004
16	oxidized low density lipoproteinIBA 01/2021 - 10/2003
16	Lipoproteins (Lipoprotein)IBA 11/2017 - 09/2005
14	CholesterolIBA 10/2023 - 04/2009
6	LDL Lipoproteins (beta Lipoproteins)IBA 05/2014 - 12/2004
4	EpitopesIBA 01/2019 - 05/2009
4	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2012
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 11/2005
4	AntibodiesIBA 10/2013 - 07/2005
3	LigandsIBA 01/2023 - 11/2005
3	LipopolysaccharidesIBA 01/2019 - 07/2010
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
3	1-penicillamyl-Leu(2)- oxytocinIBA 01/2018 - 01/2011
3	Cholesterol Esters (Cholesteryl Esters)IBA 04/2017 - 01/2011
3	ChemokinesIBA 05/2014 - 09/2009
3	CytokinesIBA 09/2012 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2004
2	Retinaldehyde (Retinal)IBA 01/2024 - 10/2023
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2013
2	Pattern Recognition ReceptorsIBA 01/2017 - 01/2011
2	Apolipoprotein C-II (ApoC2)IBA 01/2017 - 08/2015
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014 - 09/2009
2	AntigensIBA 10/2013 - 09/2012
2	C-Reactive ProteinIBA 01/2011 - 10/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2023
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2023
1	Interleukin-1 (Interleukin 1)IBA 10/2023
1	Toll-Like Receptor 4IBA 10/2023
1	SolutionsIBA 01/2020
1	Opiate AlkaloidsIBA 10/2018
1	Opioid Analgesics (Opioids)IBA 10/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	LDL CholesterolIBA 01/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Single-Chain AntibodiesIBA 01/2018
1	ApolipoproteinsIBA 11/2017
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	Fibric Acids (Fibrates)IBA 04/2016
1	ISIS 304801IBA 04/2016
1	Lipase (Acid Lipase)FDA Link 08/2015
1	Peptides (Polypeptides)IBA 08/2015
1	locked nucleic acidIBA 03/2015
1	InflammasomesIBA 03/2015
1	Angiotensin IIIBA 03/2015
1	Sirolimus (Rapamycin)FDA Link 05/2014
1	TOR Serine-Threonine KinasesIBA 05/2014

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
4	Therapeutics 01/2020 - 01/2011
1	Intravitreal Injections 10/2023
1	Injections 01/2018
1	Spinal Injections 01/2018